Gregory Wilding, PhD (Series Introduction) Professor Department of Biostatistics School of Public Health and Health Professions Director, CTSI BERD Core Michael LaMonte, PhD, MPH (Clinical Trials ...

Medically reviewed by Kate Colby, MPH Key Takeaways In a double-blind trial, neither the patient nor the researcher knows who gets the treatment.A placebo-controlled trial uses a fake drug to test ...

On 29 January 2026, NIH announced that basic experimental studies involving humans will no longer be subject to NIH Clinical ...

We will review the basics of Good Clinical Practice (GCP) and the recent updates that impact practice in an increasingly electronic environment. We will highlight the responsibilities the ...

With populations aging, chronic diseases becoming more prevalent, and global health experts warning of potential pandemics, the need for rapid therapeutic development has reached unprecedented levels.

Advocate Health is scaling clinical trial network across six states to integrate research into routine care at ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand enrolment.

Please provide your email address to receive an email when new articles are posted on . In our journey through academia, contract research organizations, big pharma and biotech startups, we have had ...